BioNano Genomics Inc vs Packaging Corporation of America — how do they compare? BioNano Genomics Inc trades at $1.15 (market cap $13.20M), while Packaging Corporation of America trades at $225.8 (market cap $20.11B). The key difference: Packaging Corporation of America is far larger — about 1523.5× BioNano Genomics Inc's market cap, and Packaging Corporation of America pays a 2.66% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | PKG | |
|---|---|---|
Market Cap | $13.20M | $20.11B |
Sector | Health | Technology |
52-Week High | $4.92 | $246.31 |
52-Week Low | $1.09 | $191.41 |
Enterprise Value | $15.81M | $23.94B |
Dividend Yield | — | 2.66% |
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
Packaging Corporation of America (PKG) trades at $225.86, down 1.27% on the day, with a bearish technical signal but oversold RSI near support at $225. Recent Q1 2026 earnings beat expectations with EPS of $2.40, though revenue growth is modest and net income margins are projected to decline. The company announced a 20% dividend increase to $6.00 annually, signaling confidence in cash flow. Analyst consensus is mixed with a Hold rating but a $254.43 price target implies 13% upside from current levels.
Outlook is cautiously optimistic given valuation support from dividends and earnings beats, but risks include margin pressure from input costs and a negative net cash flow trend. The stock's investment case hinges on execution against Q2 guidance of $2.33 EPS and management's ability to navigate cost inflation. Near-term price action will be driven by the July 23 earnings call results.
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →